liraglutide vs semaglutide vs tirzepatide A new study conducted by leading researchers across the United States suggests GLP-1s could have a much greater impact beyond obesity. Link in bio Weight Loss Injections: Liraglutide vs

ISO 62366:2007, October 2007 International Standards Organisation (2010) Needle-based injection systems for medical userequirements and test methodsPart 1: needle-based injection systems, 2nd edn

It is a controlled substance

In addition to decreasing the fluidity of the platelet membrane and promoting platelet aggregation, coagulation factors and PAI-1 (plasminogen activator inhibitor-1) will also increase under the condition of hyperglycemia, breaking the balance of coagulation and fibrinolysis and promoting thrombosis

That study enrolled 3,417 adults with obesity or overweight and without type 2 diabetes, and showed a mean weight loss of 22.7% at 68 weeks in patients who remained on treatment

Obesity poses many health risks